Structural characterization of two CD1A allelic variants

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• CD1 molecules present lipid antigens to T lymphocytes and are related to MHC molecules.
• A previously identified human CD1A allele differs from the wild type by a Cysteine to Tryptophan substitution at position 52.
• This allele's frequency varies significantly across different ethnic populations.

Purpose of the Study:

• To structurally characterize the novel human CD1A allele.
• To investigate the molecular differences between the wild type and the new CD1A allele.
• To assess the cell surface expression of the variant CD1A protein.

Main Methods:

• Cloning and sequencing of the full-length cDNA encoding the new CD1A allele.
• Transfection of wild type and mutant CD1A cDNAs into cell lines (C1R and L721.221).
• Analysis of cell surface protein expression using flow cytometry and immunoprecipitation with CD1a-specific antibodies.

Main Results:

• The new CD1A allele encodes a protein with amino acid differences at positions 14 (Threonine vs. Isoleucine) and 52 (Cysteine vs. Tryptophan) compared to the wild type.
• Both wild type and variant CD1A allelic products were found to be efficiently expressed on the surface of transfected cells.
• The structural characterization provides insights into CD1a molecule variations and their potential functional implications.

Conclusions:

• The novel human CD1A allele is structurally defined by two amino acid substitutions.
• Efficient cell surface expression of both wild type and variant CD1A molecules was confirmed.
• Further research can explore the functional consequences of these CD1A variations in immune responses.